PARSIPPANY, N.J. - Zoetis announced on Feb. 13 that it received a conditional license from the USDA's Center for Veterinary Biologics for its "Avian Influenza Vaccine, H5N2 Subtype, Killed Virus" for use in chickens.
"Our scientists routinely update our vaccines, and they began working on an updated Highly Pathogenic Avian Influenza (HPAI) vaccine in 2022 when a new strain was identified in the U.S.," the company stated, adding that, "The decision to. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
